间充质干细胞
归巢(生物学)
医学
叙述性评论
椎间盘
再生(生物学)
腰痛
干细胞
祖细胞
间质细胞
评论文章
生物信息学
病理
外科
生物
重症监护医学
细胞生物学
替代医学
生态学
作者
Andreas S. Croft,Svenja Illien‐Jünger,Sibylle Grad,Julien Guerrero,Sebastian Wangler,Benjamin Gantenbein
摘要
Chronic low back pain (LBP) remains a challenging condition to treat, and especially to cure. If conservative treatment approaches fail, the current “gold standard” for intervertebral disc degeneration (IDD)-provoked back pain is spinal fusion. However, due to its invasive and destructive nature, the focus of orthopedic research related to the intervertebral disc (IVD) has shifted more towards cell-based therapeutic approaches. They aim to reduce or even reverse the degenerative cascade by mimicking the human body’s physiological healing system. The implementation of progenitor and/or stem cells and, in particular, the delivery of mesenchymal stromal cells (MSCs) has revealed significant potential to cure the degenerated/injured IVD. Over the past decade, many research groups have invested efforts to find ways to utilize these cells as efficiently and sustainably as possible. This narrative literature review presents a summary of achievements made with the application of MSCs for the regeneration of the IVD in recent years, including their preclinical and clinical applications. Moreover, this review presents state-of-the-art strategies on how the homing capabilities of MSCs can be utilized to repair damaged or degenerated IVDs, as well as their current limitations and future perspectives.
科研通智能强力驱动
Strongly Powered by AbleSci AI